The TPP could impose new rules that will extend monopoly protections for pharmaceutical companies, keeping prices sky-high for longer and blocking less expensive generic drugs that are vital to global health from entering the market.

As a medical humanitarian organization working in nearly 70 countries, MSF is concerned about the impact the deal will have on public health in developing countries where the organization works, and beyond. MSF urges the U.S. government to withdraw -- and other TPP negotiating countries such as Canada to reject -- rules that threaten to dismantle internationally-agreed public health safeguards and restrict access to medicines in developing countries. /YT